Role of Baseline HIV-1 DNA Level in Highly-Experienced Patients Receiving Raltegravir, Etravirine and Darunavir/Ritonavir Regimen (ANRS139 TRIO Trial)

OBJECTIVE: In the ANRS 139 TRIO trial, the use of 3 new active drugs (raltegravir, etravirine, and darunavir/ritonavir), resulted in a potent and sustained inhibition of viral replication in multidrug-resistant treatment-experienced patients. The aim of this virological sub-study of the ANRS 139 TRI...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Charpentier, Charlotte, Fagard, Catherine, Colin, Céline, Katlama, Christine, Molina, Jean-Michel, Jacomet, Christine, Visseaux, Benoit, Taburet, Anne-Marie, Brun-Vézinet, Françoise, Chêne, Geneviève, Yazdanpanah, Yazdan, Descamps, Diane
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2013
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3547918/
https://ncbi.nlm.nih.gov/pubmed/23349724
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0053621
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados